Amanote Research
Register
Sign In
P1.01-103 Leukocyte Telomere Length as a Novel Biomarker in Advanced Lung Adenocarcinoma Patients Treated With Gefitinib
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.660
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Yang
J. Li
N. Zhang
J. Liu
H. Xing
Publisher
Elsevier BV
Related search
Leukocyte Telomere Length in Patients With Radiographic Knee Osteoarthritis
Environmental and Molecular Mutagenesis
Mutagenesis
Toxicology
Health
Genetics
Epidemiology
Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma
Tuberculosis and Respiratory Diseases
Pulmonary
Infectious Diseases
Respiratory Medicine
P1.01-109 Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-29 Crizotinib in Advanced Lung Adenocarcinoma Patients With ALK or ROS-1 Rearrangement: Is It the Same?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-110 Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated With Afatinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combination of Chemotherapy and Gefitinib as First-Line Treatment for Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: A Randomized Controlled Trial
International Journal of Cancer
Cancer Research
Oncology
Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib
British Journal of Cancer
Cancer Research
Oncology
MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
Cancer Research
Oncology